DOCMF (Dr. Martens) Change In Working Capital: $26 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DOCMF Dr. Martens PLC DOCMF
55 GF Score
Price $0.98
GF Value $0.97
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Dr. Martens Change In Working Capital?

Dr. Martens DOCMF -0.04% 55 Change In Working Capital is $26 Mil as of Mar. 2026. GuruFocus rates DOCMF with a GF Score™ of 55/100 and a GF Value™ of $0.97 (Fairly Valued). The stock has 3 warning signs investors should review.

Dr. Martens's change in working capital for the quarter that ended in Mar. 2026 was $83 Mil.

Dr. Martens's change in working capital for the fiscal year that ended in Mar. 2026 was $26 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).


Dr. Martens Change In Working Capital Related Terms


Dr. Martens Change In Working Capital Historical Data

* Premium members only.

The historical data trend for Dr. Martens's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr. Martens Change In Working Capital Chart

Dr. Martens Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Change In Working Capital
Get a 7-Day Free Trial Premium Member Only -56.13 -180.83 -18.81 108.92 26.40

Dr. Martens Semi-Annual Data
Mar18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Change In Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 92.50 13.89 95.35 -57.70 83.33
DOCMF
55GF Score
Dr. Martens PLC DOCMF
Change In Working Capital is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr. Martens Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $26 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows Fiscal Years EndedJanuary 31,(Amounts in millions)
Cash flows from operating activities: 2014 2013 2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net (566) (614) (796)
Inventories (1,667) (2,759) (3,727)
Accounts payable 531 1,061 2,687
Accrued liabilities 103 271 (935)
Accrued income taxes (1,224) 981 994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Change In Working Capital of $26 Mil mean?
Dr. Martens (DOCMF) has a Change In Working Capital of $26 Mil as of Mar. 2026. Change in Working Capital is the difference between current assets less current liabilities between the current period and the past period. View historical data for Dr. Martens.
Is Dr. Martens' Change In Working Capital too high?
Dr. Martens' current Change In Working Capital is $26 Mil. Overall, Dr. Martens has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' Change In Working Capital compare to NKE and DECK?
Dr. Martens' Change In Working Capital of $26 Mil can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Working Capital for a Manufacturing - Apparel & Accessories company?
A good Change In Working Capital depends on the Manufacturing - Apparel & Accessories industry context. However, Change In Working Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Working Capital mean?
A high Change In Working Capital can signal that a stock is expensive relative to its fundamentals. Change in Working Capital is the difference between current assets less current liabilities between the current period and the past period. View historical data for Dr. Martens. Dr. Martens's current Change In Working Capital is $26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (DOCMF) is currently considered Fairly Valued. The stock's GF Value™ is $0.97, compared to a current price of $0.98 — trading 1.3% above its estimated fair value. The current Change In Working Capital is $26 Mil. Dr. Martens' overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Working Capital calculated?
Change In Working Capital is calculated from a company's financial statements. For Dr. Martens (DOCMF), the current Change In Working Capital is $26 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr. Martens (DOCMF) Overvalued in 2026?

Based on GuruFocus' analysis, Dr. Martens stock appears to be overvalued. The current stock price of $0.98 is trading 1.3% above its estimated GF Value™ of $0.97. GuruFocus considers Dr. Martens to be Fairly Valued.

Key valuation signals for DOCMF:

  • Change In Working Capital: $26 Mil
  • GF Value™: $0.97 vs. price of $0.98 (1.3% above fair value)
  • GF Score™: 55/100 with 3 warning signs

No single metric tells the full story. See the DOCMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dr. Martens Business Description

Address 28 Jamestown Road, Camden, London, GBR, NW1 7BY
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
55GF Score

Get the complete analysis for DOCMF

Change In Working Capital is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.98
Price
$0.97
GF Value